SlideShare a Scribd company logo
1 of 154
Rachel Hagemann, RPh
Krista Sanders, CPhT
October 10, 2015
Cerner Millennium®:
mCDS – Making
Clinical Alerts
Meaningful
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
1
Learning Record Transfer
• Transfer Learning Record from CLM to uLearn
• If you have not already done this.
• https://ulearn.cerner.com
• Sign in with your Cerner Care email address and password.
• Follow instructions on main page.
• If you have questions about your learning record, please contact
LearningSolutions@Cerner.com
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
2
Objectives
• Understand clinical alerts
• Understand meaningful alerts
• Be able to use the functionality within
medication clinical decision support (mCDS) to
create meaningful alerts
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
3
Agenda
• mCDS Introduction
• Venue of Care Filtering
• Preferences
• Customization
• Drug Allergies
• Drug Drug
• Duplication Checking
• Repeat Numbers
• Using Discern Rules
• Discern alerts displayed within mCDS
• Filtering drug drug interactions using discern rules
• Order Detail Filtering
• TPNs
• Alert Maintenance
• Questions/Examples
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
4
Scheduled Break Times
• After Venue of Care Filtering
• Lunch
• Noon
• Snack
• 2:10
• PRN
Medication Clinical Decision
Support (mCDS) Overview
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
6
mCDS Objective
Is that Cerner solutions no longer
filters medication alerts that are a
nuisance, but create meaningful
alerts that enhance safety and
improve patient care.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
7
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
8
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
9
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
Packages
• mCDS package
• Innovations Dev (US): Medication Clinical Decision Support
Window
• Need 83848 or higher
• MultumCustom.exe
• Need 68066 or higher
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
Nuisance Alerts
• Not unique to Cerner solutions
• Have seen studies where up to 85% of the alerts are
ignored
• Not unique to drug content provider
• Cerner Multum
• FDB (First Databank)
• Medi-Span
• Varies across venues of care
• Ambulatory vs. Inpatient
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
What’s the cause of nuisance alerts?
• Conservative nature of content produced by
commercial vendors
• Cerner Multum/FDB/Medi-Span
• Lack of context from not considering available data,
objectives, role, and venue of care
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
15
Approach to reducing nuisance alerts has been to
reduce the “noise”, not to make them meaningful
• Turn alerting off
• Mainly drug drug and duplicate therapy
• Leave allergy checking on
• Disable lower severity alerts
• “Fine tune” higher severity alerts
• Government recommendations (FDA)
16
ASHP Committee
17
Healthcare Informatics Article – mCDS
18
JAMIA Article – Duplicate Therapy Checking
19
Duplicate Checking Analysis
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
20
mCDS Development Approach
• Improve the user experience
• Enhance the user interface
• Address major functional gaps/limitations
• Improve ability to “localize” the experience
• Required changes and “tightening”
• Meaningful use
• “Bugs”/Client feedback
• Incorporate Discern capabilities
• Filter alerts based upon order details
• Existing ADE packages, local rules
• Utilize future Cerner capabilities
• Cerner Math
• DAAKOS
• Hansten and Horn
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
21
Meaningful Use
• Stage 1
• Drug allergy checking
• Drug drug interaction checking
• Stage 2
• Citations
• Allergies
• Drug Interactions
• Requirements
• mCDS window
• Latest/Greatest Cerner Multum content package
• Stage 3
• Cerner working on requirements
22
Allergy Citation Indicator
23
Allergy Citation
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
24
Drug Drug Interaction Citation
• Select icon next to the drug interaction pair to display
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
25
AHS_FL Alert Reduction since implementing
mCDS Window
User Interface Improvements
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
27
Window Improvements
• Window defaults to all sections open – ability to
collapse individual sections or all sections
• Triggering and existing medications display honors
MNEM_DISP_LEVEL preference
• Additional order information available via order detail
tool tip
• Triggering and existing medications display Simplified
Display Line
• Drug reference, patient leaflets, and alert history
accessed from hyperlink on medication order
• Ability to discontinue medication being ordered and
profile medication from the mCDS window
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
28
Window Improvements
• Ability to identify orders as historical, prescription, or
an inpatient medication order
• Severity level of interaction is displayed in text, not an
icon, with Major Contraindicated interactions color
coded in red
• Access additional interaction information via a
hyperlink
• Allergy and drug drug interaction citation information
available
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
29
Allergy Improvements
• Access allergy control via a hyperlink
• Allergy Comments, Reaction Type, and Information
Source are displayed
• Allergy Citation information is available – Meaningful
Use requirement
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
30
Override Reasons Improvements
• Override Reason selection available for individual
alerts
• Previous Override Reason is available
• “Apply to All” Override Reasons configurable in
Bedrock
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
31
mCDS Alert Override Reasons
• Design Decisions
• Not Required
• Required
• Which application(s)
• Which alert type(s)
• Which provider(s)
• Which individual(s)
• Configure in PrefMaint.exe
• PowerChart  Chart  PowerOrders
• MUL_OVERRIDEREQUIRED (0 =Override Reason not required; 1=
Override Reason Required)
• MUL_OVERRIDEREQUIRED_TYPE
• Pharmacy
• MUL_OVERRIDEREQUIRED_TYPE
• Bedrock
• Override Reason filters for All Alert Types and each specific Alert Type
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
32
Requiring Override Reasons in PowerChart
• Configure in PrefMaint.exe
• PowerChart  Chart  PowerOrders 
MUL_OVERRIDEREQUIRED and
MUL_OVERRIDEREQUIRED_TYPES
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
33
Requiring Override Reasons in Med
Manager
• Configure in PrefMaint.exe
• Pharmacy  MUL_OVERRIDEREQUIRED_TYPES
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
34
Override Reasons Display
• Bedrock Override Reasons Filters
• In order for an Override Reason to be available for “Apply to
All” it must be included in the “Override Reason for all Types”
filter
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
35
mCDS Discontinue Reasons
• Design Decisions
• Not Required
• Required
• What reasons to display
• Configure
• DCPTools.exe  Order Management  Order Entry Format
Tool  Formats  Pharmacy Order Entry Formats 
Discontinue Order Action  Discontinue Reasons Field
• Discontinue format build is required or mCDS window will
display an error
• Selections for field: Do Not Display, Display Only, Optional,
Required
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
36
Discontinue Reason Format
Selections for field: Do Not
Display, Display Only, Optional,
Required
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
37
mCDS Discontinue Reasons
• Must use code set 1309 for the drop down
• DCPTools.exe  Order Management  Order Entry Format
Tool  Fields  Discontinue Reason
• Must use Meaning of Discontinue Reason
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
38
Filtering Discontinue Reasons
• Configure in Bedrock
• Design, Build and Maintenance  Core – Orders  Order Entry
Field Value (Code Set) Filtering  Discontinue Reason (Code Set
1309)
• Catalog Type
• Activity Type
• Orderable
Venue of Care Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
40
Agenda for Venue of Care Filtering
• Description
• Diagrams
• Diagrams – a second time
• How to set up
• Example
• Questions????
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
41
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
42
Venue of Care Filtering
• Definition
• Filtering of all alert types (drug drug, drug food, drug allergies,
and duplicate therapy) when moving from home
(prescriptions) to inpatient and back to prescriptions.
• Rationale for filtering alerts
• Reduction of nuisance alerts when patients move across
venues of care (prescriptions (home) to inpatient to
prescriptions).
• Customization
• Bedrock mCDS wizard
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
43
Venue of Care Filtering
• Applies to all alert types
• Drug Drug
• Drug Food
• Drug Allergy
• Duplicate Therapy
• Filters are in Bedrock
• Code set extension settings in CoreCodeBuilder.exe no longer
honored
• Home Medication to Inpatient Filtering (HXIP)
• Inpatient Filtering (IP)
• Inpatient to Prescription Filtering (IPRX)
• Prescription Filtering (RX)
• Filtering applies to all solutions and position codes
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
44
Venue Filters Off
• When all venue of care filters are off, checking will
occur across documented home medications, inpatient
orders, and prescription orders.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
45
Venue of Care Filtering
• Venue of Care Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
46
Venue of Care Filtering -- HXIP
• No alerts
• HXIP filtering on – No checking against medications when moving
from home meds to inpatient orders
• potassium chloride and diphenhydrAMINE drug drug interaction suppressed
• diphenhydrAMINE and loratadine duplicate checking suppressed
• same orderable duplicate checking suppressed
• This filter will always occur across solutions
HXIP Alerts Filtered
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
47
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
48
Venue of Care Filtering -- IP
• No alerts
• IP filtering on – No checking between medications continued
as inpatient orders
• Potassium chloride and diphenhydrAMINE drug drug interaction
suppressed
• diphenhydrAMINE and loratadine duplicate checking suppressed
• One time blocking
• Second time (e.g., verification by pharmacy) will see this alert
IP Alerts Filtered
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
49
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
50
Venue of Care Filtering -- IPRX
• No alerts
• IPRX filtering on – No checking against inpatient medications when
moving from inpatient meds to prescription orders
• This filter will always occur across solutions IPRX Alerts Filtered
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
51
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
52
Venue of Care Filtering -- RX
• No alerts
• RX filtering on – No checking between inpatient medications
continued as prescription orders
 Alert Checking does occur for medications that were not continued from
inpatient order – hydrOXYzine was not an inpatient medication
• One time blocking
• Second time will see this alert RX Alerts Filtered
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
53
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
54
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
55
Venue of Care Filtering
• Venue of Care Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
56
Venue of Care Filtering
• Bedrock.exe  Quality Reporting and MPages  MPage Setup
 Medication Clinical Decision Support (mCDS)
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
57
Venue of Care Filtering
• Home Medication to Inpatient Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
58
Venue of Care Filtering
• Home Medication to Inpatient Filtering
• This setting determines if clinical checking will be filtered
between history and inpatient venues. This filter will be used
when an order moves from history to inpatient
venue(s) of care or an inpatient order is placed.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
59
Venue of Care Filtering
• Home Medication to Inpatient Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
60
CoreCodeBuilder.exe
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
61
Venue of Care Filtering
• Inpatient Filtering
• This setting is used to determine how clinical checking is
filtered during the patient’s inpatient stay. If enabled, one-time
blocking of clinical checking (drug drug, drug food, drug
allergy, duplicate therapy) will occur within the “inpatient”
venue of care.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
62
Venue of Care Filtering
• Inpatient Medication Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
63
Venue of Care Filtering
• Inpatient to Prescription
• This setting determines if clinical checking will be filtered
between inpatient and discharge venues. This filter will be
used when an order moves from inpatient to discharge
venue(s) of care or an inpatient or prescription order is placed.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
64
Venue of Care Filtering
• Inpatient to Prescription Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
65
Venue Filtering
• Prescription Filtering
• This setting is used to determine how clinical checking is
filtered when prescriptions are prescribed. If enable, one-time
blocking of clinical checking (drug drug, drug food, drug
allergy, duplicate therapy) will occur within the discharge
venue of care.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
66
Venue of Care Filtering
• Prescription Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
67
Venue of Care Filtering
• Example
• HXIP – On
• IP – On
• IPRX – On
• RX – On
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
68
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
69
Venue of Care Filtering
• No alerts
• No duplicate checking against the same medications because
of HXIP from hx meds to inpatient orders
• IP blocked inpatient orders
• Potassium chloride and diphenhydrAMINE drug drug interaction
• diphenhydrAMINE and loratadine duplicate checking
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
70
Venue of Care Filtering
• Alert when ordering potassium chloride IV
• Potassium chloride IV was not a hx med therefore it checked
against all current inpatient orders
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
71
Venue of Care Filtering
• Orders to be verified by pharmacy
• The one time blocking has occurred in PowerChart therefore
there will not be any IP blocking when verifying
• If orders are entered directly in PharmNet then the one time
blocking of IP will apply
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
72
Venue of Care Filtering
• Alert with diphenhydrAMINE and potassium chloride IV
• The one time blocking has occurred in PowerChart therefore
there will not be any IP blocking when verifying
• If orders are entered directly in PharmNet then the one time
blocking of IP will apply
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
73
Venue of Care Filtering
• Alert for loratadine and diphenhydrAMINE
• The one time blocking has occurred in PowerChart therefore
there will not be any IP blocking when verifying
• If orders are entered directly in PharmNet then the one time
blocking of IP will apply
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
74
Venue of Care Filtering
• Alert when verifying potassium chloride IV
• Potassium chloride IV was not a hx med therefore it checked against
all current inpatient orders
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
75
Venue of Care Filtering
• Pharmacy orders are verified
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
76
Venue of Care Filtering
• Discharging the patient
• No alerts
• No duplicate checking against the same medications because
of IPRX from inpatient meds to prescription orders
• RX blocked prescription orders
• Potassium chloride and diphenhydrAMINE drug drug interaction
• diphenhydrAMINE and loratadine duplicate checking
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
77
Venue of Care Filtering
• Alert against the home medication hydrOXYzine and
diphenhydrAMINE
• hydrOXYzine was a hx med and not an inpatient medication therefore
it will be checked against prescription medications
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
78
Venue of Care Filtering
• Alert against the home medication hydrOXYzine and
loratadine
• hydrOXYzine was a hx med and not an inpatient medication
therefore it will be checked against prescription medications
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
79
Venue of Care Filtering
• Alert against the home medication hydrOXYzine and
potassium chloride
• hydrOXYzine was a hx med and not an inpatient medication
therefore it will be checked against prescription medications
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
80
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
81
Venue of Care Filtering
• Venue of Care Filtering
• Questions????
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
82
“Mr. Osborne,
may I be
excused?
My brain is full.”
Preferences
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
84
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
85
MULPREF
• Turns on Multum within Matrix Orders.
• 1-On
• 0-Off
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
86
MUL_DS_STYLE
• This preference determines the style of the
interaction checking window.
• 1-Use enhanced window
• 0-Use classic window
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
87
MUL_MPAGE_VIEW
• Determines if the Medication Clinical Decision
Support (mCDS) view is enabled for Multum
interaction checking. When the value is set to
1 or 2, the preference MUL_DS_STYLE=1
(Use Enhanced View) must also be set.
• 1-On for Add Order or Product
• 0-Off
• 2-On for Sign Order or OK
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
88
MUL_OVERRIDEREQUIRED
• This preference determines whether an
Override Reason must be entered in order to
close the alert window.
• 1-Override reason required
• 0-Override reason not required
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
89
MULINTR
• This preference determines whether to
perform interaction checking when medication
orders are placed using Matrix Orders.
• 1-Interaction checking
• 0-No interaction checking
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
90
MUL_INTRSEVERITY
• This preference determines at what level
interaction checking will occur.
• 5-Major Contraindicated
• 3-Major
• 2-Moderate
• 1-Minor
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
91
MUL_INTERPRETEDSEVERITY
• This preference determines if interaction
checking should be performed based on
traditional Multum severities or on interpreted
severities using the interaction severity and
interaction severity heading. Note that any
customized severities will override the
interpreted severity.
• 0-Use traditional Multum severities
• 1-Use interpreted severities
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
92
MULREAT
• This preference determines whether to
perform allergy checking for medication orders
using Matrix Orders.
• 1-Allergy checking
• 0-No allergy checking
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
93
MUL_ALLERGYINTERRUPTION
• Determines whether to display the interaction
checking window for allergy reactions.
• 0-Display
• 1-Do not display
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
94
MUL_ALLERGY_REACTIONCLASS_FILTER
• This preference determines which types of
allergy reaction class's should be filtered out of
drug-allergy and reverse allergy interaction
checking. This preference is only used when
MUL_DS_STYLE is set to 1.
• The preference is a comma-separated list of
allergy reaction class codes from code set
12021. For example “3291,3292”
• Adverse Effect
• Side Effect
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
95
MULDUP
• This preference determines whether to
perform duplicate checking when medication
orders are placed using Matrix Orders.
• 1-Duplicate checking
• 0-No duplicate checking
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
96
MUL_DUPINTERRUPTION
• This preference determines whether the
interaction checking window will display when
ordering duplicate medications.
• 0-Display
• 1-Do not display
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
97
MULDUPCHECKPREF
• This preference determines the manner in
which duplicate checking is performed for
Pharmacy orders.
• 2-Dups against both
• 0-Dups against scratchpad
• 1-Dups against existing orders
• 3-Dups against scratchpad minus same CKI’s
• 4-Dup against sp minus same cki and existing
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
98
MULDUPMODE
• This preference determines when the
duplicate checking window will display.
• 2-Both
• 0-Single Drug
• 1-Category
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
99
MULDUPCAT
• This preference determines the level of
duplicate checking when different drugs have
identical or similar clinical effects. This
preference is only used when MULDUPMODE
is set to Category or Both.
• C-Very Specific
• B-General
• A-Very General
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
0
MULDUPCLASS
• This preference determines whether duplicate
therapy checking should be applied across
both inpatient and outpatient drugs or to check
exclusively inpatient or outpatient drugs.
• 1-Mutually Exclusive
• 0-All
MultumCustom.exe
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
2
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
3
MultumCustom.exe
Drug Drug Interaction
• Severity
• Severity Header
• Suppression
• Text
Duplicate Therapy Checking
• Repeat Numbers – Must have package number 68066 or higher
installed
• Duplication Category
• Drug
• Suppression
• Duplication Category
• Drug
Drug Allergy Checking
• Drug to Drug
• Allergy Category to Drug
Reference Text
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
4
Duplicate Therapy
• Suppression
•Duplication Category
• Drug
• Repeat Number
• Duplication Category
• Drug
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
5
Duplication Therapy Searches
Drug
• Individual drug
Category
• All individual drugs within a drug category
Duplication Category
• The actual duplication category
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
6
Duplicate Therapy
• Example
• Laxatives
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical
Decision Support
• https://wiki.ucern.com/display/public/reference/All+About
+Medication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
7
Drug Allergy
• Allergy Category
• Suppression of documented allergy
category
• Additional searches
• Allergy Category Drug
• The documented allergy category to a drug
• Allergy Category Category
• The documented allergy category to all individual drugs within a drug category
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
8
Drug Allergy
Drug Drug
• Individual drugs
• e.g. oxyCODONE / meperidine
Category Drug
• All individual drugs within a drug category to a drug
• e.g. penicillins / aztreonam
Category Category
• All individual drugs within categories
• e.g. loop diuretics / sulfonamides
Allergy Category Drug
• The documented allergy category to a drug
• e.g. penicillins / aztreonam
Allergy Category Category
• The documented allergy category to all individual drugs within a
drug category
• e.g. loop diuretics / Sulfa drugs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
10
9
Drug Allergy
• Example
• Sulfa Drugs and Loop Diuretics
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical
Decision Support
• https://wiki.ucern.com/display/public/reference/All+About
+Medication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
0
Drug Allergy Suppression Client Example
Suppression
loop diuretics (category) / sulfonamides (category)
loop diuretics (category) / sulfa drugs (allergy category)
loop diuretics (category) / sulfonamides (allergy category)
loop diuretics (category) / COX-2 inhibitors (category)
penicillins (allergy category) / aztreonam (drug)
penicillins (category) / aztreonam (drug)
codeine (drug) / meperidine (drug)
codeine (drug) / fentanyl (drug)
morphine (drug) / meperidine (drug)
oxyCODONE (drug) / meperidine (drug)
oxyCODONE (drug) / fentanyl (drug)
fentaNYL (drug) / HYDROmorphone (drug)
meperidine (drug) / acetaminophen-oxycodone (drug)
meperidine (drug) / HYDROmorphone (drug)
acetaminophen-propoxyphene (drug) / HYDROmorphone (drug)
acetaminophen-propoxyphene (drug) / acetaminophen-oxycodone (drug)
acetaminophen-hydrocodone (drug) / meperidine (drug)
nalbuphine (drug) / meperidine (drug)
carbapenems (category) / third generation cephalosporins (category)
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
111
Drug Allergy Suppression Most Questioned/Reviewed
Sulfonamides and Related Compounds Classification
carbonic anhydrase inhibitor sulfonylurea sulfonamide
d00161 acetaZOLAMIDE d00162 acetoHEXAMIDE d04428 amprenavir
d04301 brinzolamide ophthalmic d00042 chlorproPAMIDE d04301 brinzolamide ophthalmic
d00639 dichlorphenamide d03864 glimepiride d04380 celecoxib
d03805 dorzolamide ophthalmic d00246 glipiZIDE d05825 darunavir
d00640 methazolamide d00248 glyBURIDE d00129 diazoxide
sulfa topical d00393 TOLAZamide d04901 fosamprenavir
d01258 mafenide topical d00394 TOLBUTamide d00031 probenecid
d01259 silver sulfADIAZINE topical thiazide or thiazide-like diuretic d08182 simeprevir
d01208 sulfacetamide sodium ophthalmic d00641 bendroflumethiazide d00118 sulfADIAZINE
d01265 sulfacetamide sodium topical d00644 benzthiazide d03742 sulfadoxine
d01240 sulfanilamide topical d00190 chlorothiazide d01090 sulfamethizole
d03980 sulfiSOXAZOLE ophthalmic d00253 hydrochlorothiazide d00119 sulfamethoxazole
d03231 triple sulfa topical d00645 hydroflumethiazide d00379 sulfaSALAzine
sulfonamide-type loop diuretic d00260 indapamide d00120 sulfiSOXAZOLE
d00179 bumetanide d00643 methyclothiazide d07942 sulfonated phenolics topical
d00070 furosemide d00647 polythiazide d04121 tamsulosin
d03189 torsemide d00646 trichlormethiazide d05538 tipranavir
sulfone thiazide-like diuretic d04778 valdecoxib
d00098 dapsone d00192 chlorthalidone d04527 zonisamide
d05543 dapsone topical d00299 metolazone
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
2
Drug Allergy Suppression Most Questioned/Reviewed
Penicillins and Related Drugs Classification
beta lactamase inhibitor cephalosporin
d04405 clavulanate d00081 cefaclor
d04403 sulbactam d00080 cefadroxil
d04404 tazobactam d00062 cefamandole
carbapenem d00007 ceFAZolin
d07049 doripenem d04256 cefdinir
d04783 ertapenem d04767 cefditoren
d04401 imipenem d03882 cefepime
d04027 meropenem d00072 cefixime
monobactam d00093 cefmetazole
d00067 aztreonam d00063 cefonicid
penicillin d00074 cefoperazone
d00088 amoxicillin d00008 cefotaxime
d00003 ampicillin d00055 cefoTEtan
d00151 bacampicillin d00094 cefOXitin
d00092 carbenicillin d00095 cefpodoxime
d00152 cloxacillin d00073 cefprozil
d00153 dicloxacillin d07706 ceftaroline
d00107 methicillin d00009 cefTAZidime
d00109 mezlocillin d03874 ceftibuten
d00029 nafcillin d00010 ceftizoxime
d00115 oxacillin d00052 cefTRIAXone
d00116 penicillin d00056 cefuroxime
d07727 penicillin G benzathine d00096 cephalexin
d07729 penicillin G potassium d00186 cephalothin
d07728 penicillin G sodium d00187 cephapirin
d07730 penicillin V potassium d00053 cephradine
d00057 piperacillin d00105 loracarbef
d07390 procaine penicillin
d00121 ticarcillin
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
3
Drug Allergy Suppression Most Questioned/Reviewed
Narcotic Analgesics Classification
methadone-like opiate phenanthrene derivative
d03187 levomethadyl acetate d04991 apomorphine
d00050 methadone d00840 buprenorphine
d00360 propoxyphene d00838 butorphanol
opioid-like analgesic d04251 butorphanol nasal
d03826 traMADol d00012 codeine
phenylpiperidine derivative d00837 dezocine
d00167 alfentanil d03168 dihydrocodeine
d03069 difenoxin d03877 heroin (Schedule I substance)
d03071 diphenoxylate d03075 HYDROcodone
d00233 fentaNYL d00255 HYDROmorphone
d04313 fentanyl topical d00825 levorphanol
d00017 meperidine d00308 morphine
d04034 remifentanil d05295 morphine liposomal
d00378 SUFentanil d00839 nalbuphine
d00824 opium
d00329 oxyCODONE
d00833 oxymorphone
d00334 pentazocine
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
4
Drug Drug
• Suppression
• Severity
• Major
• Moderate
• Minor
• Header Severity
• Contraindicated
• Major and Contraindicated is the major contraindicated
preference
• Generally Avoid
• Monitor Closely
• Adjust Dosing Interval
• Adjust Dose
• Additional Contraception Recommended
• Monitor
• Monograph Text
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
5
Drug Drug
Drug Drug
• Individual drugs
Category Drug
• All individual drugs within a drug category to a drug
Category Category
• All individual drugs within categories
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
6
Drug Drug
• Example
• Customizing to Major Contraindicated
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical
Decision Support
• https://wiki.ucern.com/display/public/reference/All+About
+Medication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
Filtering Medication Alerts
Using Discern Expert
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
8
Filtering Medication Alerts Using Discern Expert
• Apply Discern Expert rules to interaction pairs
• Display additional information
• Suppress alerts based on patient parameters
• The Discern Expert rule is built in Discern EKM
Development application available in Discern Launch
• Evoke MUST be SYNCHEVENT
• Rule firing will not result in the mCDS window displaying;
result will display when other alert types involving the
interaction pair have fired, displaying the window
• The Expert Synch trigger is included in multumcustom.exe
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
11
9
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
0
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
1
Filtering Medication Alerts Using Discern Expert
• Examples
• Suppression drug drug interactions based on lab values
• Displaying Lab Values
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
TPN
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
3
TPN
• Filters within the TPN when TPNs are built as an IV set
• Alert before the filter is applied
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
4
• Filtering duplication checking within a TPN
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
TPN
Order Detail Filtering
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
6
Order Detail Filtering
• Create meaningful alerts that enhance safety
and improve patient care by making alert more
patient specific.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
7
Order Detail Filtering
• Examples
• Filter out specific alerts for providers
• Cardiologic vs. Infection Control Physician
• Filter out alerts for due to specific routes
• Anticholinergents and Potassium Chloride
• Ciprofloxacin and Antacids
• Allow multiple drugs to be ordered based on PRN
reason
• Narcotic Analgesics
• Allow multiple drugs to be ordered based on
frequency
• Midazolam
• Aspirin and NSAIDs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
8
Order Detail Filtering
• Examples
• Filter out specific alerts for providers
• Cardiologic vs. Infection Control Physician
• Filter out alerts for due to specific routes
• Anticholinergents and Potassium Chloride
• Ciprofloxacin and Antacids
• Allow multiple drugs to be ordered based on PRN
reason
• Narcotic Analgesics
• Allow multiple drugs to be ordered based on
frequency
• Midazolam
• Aspirin and NSAIDs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
12
9
Order Detail Filtering
• Examples
• Filter out specific alerts for providers
• Cardiologic vs. Infection Control Physician
• Filter out alerts for due to specific routes
• Anticholinergents and Potassium Chloride
• Ciprofloxacin and Antacids
• Allow multiple drugs to be ordered based on PRN
reason
• Narcotic Analgesics
• Allow multiple drugs to be ordered based on
frequency
• Midazolam
• Aspirin and NSAIDs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
0
Order Detail Filtering
• Examples
• Filter out specific alerts for providers
• Cardiologic vs. Infection Control Physician
• Filter out alerts for due to specific routes
• Anticholinergents and Potassium Chloride
• Ciprofloxacin and Antacids
• Allow multiple drugs to be ordered based on PRN
reason
• Narcotic Analgesics
• Allow multiple drugs to be ordered based on
frequency
• Midazolam
• Aspirin and NSAIDs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
1
Order Detail Filtering
• Examples
• Filter out specific alerts for providers
• Cardiologic vs. Infection Control Physician
• Filter out alerts for due to specific routes
• Anticholinergents and Potassium Chloride
• Ciprofloxacin and Antacids
• Allow multiple drugs to be ordered based on PRN
reason
• Narcotic Analgesics
• Allow multiple drugs to be ordered based on
frequency
• Midazolam
• Aspirin and NSAIDs
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
2
Order Detail Filtering
• Filtering alerts based on orderable or drug
category and order entry format fields
• Strength dose
• Volume dose
• Duration
• Route
• Dosage form
• Frequency
• PRN reason
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
3
Order Detail Filtering
• Build in Bedrock
• Filtering of orderable and order details
• When a second order is placed with the same data an alert
will fire
• Based on orderable or drug category
• Based on order entry details
• Can be based on provider’s position
• At least one orderable/drug category and one
order entry detail are required
• Up to four different scenarios
• Next package will have 10 filters
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
4
Order Detail Filtering
• Bedrock.exe  Quality Reporting and MPages  MPage Setup
 Medication Clinical Decision Support (mCDS)  Order Detail
Filtering Group
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
5
Order Detail Filtering
• Examples
• Potassium Chloride and Anticholinergic Medications
• Narcotics with Different PRN Reasons
• Amlodipine and Strength of Simvastatin
• Position Filtering
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
mCDS Set Up
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
7
mCDS Set Up
• Set preferences
• Run Bedrock Wizard for Multum content
• Up to date Multum content
• Attach missing CKI’s
• Use meds_cki_utility to remove incorrect CKI’s
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
8
mCDS Set Up
• Develop the scenario
• Criteria for filtering
• Primary level
• Drug drug interactions
• Drug allergies
• Drug duplication
• Criteria on patient’s profile
• Lab values
• Age
• Order Detail Specific
• PRN reason
• Route
• Doseform
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
13
9
mCDS Set Up
• For better maintenance customize or filter at the
highest level
• Preference
• Multumcustom.exe
• Drug drug interactions at primary level
• Duplicate Therapy suppression and repeat numbers
• Allergies at primary level
• Discern Alerts
• Lab Values
• Age
• Order Detail Filtering
• PRN reason
• Route
• Doseform
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
0
Trouble Shooting
• Order Detail Filtering
• Run scenario without filter and get an alert
• This will let you know if there is something else not set
correctly
• CKI
• Preference
• Other Customizations
• Set up filter
• If multiple order details try setting one test and then set
the second one
• Run scenario not to receive an alert
• Run scenario to receive an alert
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
1
Trouble Shooting
• When receiving an alert and not expecting an
alert
• Use the duplicate therapy text to find out if it is an
individual drug or class duplicate
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
2
Trouble Shooting
• Use Check Interactions before signing the
order.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
3
Trouble Shooting
• Use Alert History when still verifying or
ordering.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
4
Trouble Shooting
• Use Alert History after the order has been
signed.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
5
Trouble Shooting
• Use Alert History after the order has been
submitted.
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
6
mCDS Set UP
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet
Inpatient Reference Pages  All About Medication
Clinical Decision Support
• https://wiki.ucern.com/display/public/reference/All+
About+Medication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios
Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
Alert Maintenance
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
8
Alert Maintenance
• The ability to turn on alerts for only certain
drug orderables or drug categories.
• Allergies
• Drug Duplicates
• Set up in Bedrock
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
14
9
Alert Maintenance
• Alert Maintenance
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical
Decision Support
• https://wiki.ucern.com/display/public/reference/All+About
+Medication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
Scenario Document
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
15
1
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved.
This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner
15
2
Documentation for mCDS
• All About Medication Clinical Decision Support
• Dashboard  Reference Pages  PharmNet Inpatient
Reference Pages  All About Medication Clinical Decision
Support
• https://wiki.ucern.com/display/public/reference/All+About+Med
ication+Clinical+Decision+Support
• Go under the additional information hyperlink
• Medication Clinical Decision Support (mCDS) Scenarios Build
• Venue of Care Filtering PowerPoint
• mCDS – Making Clinical Alerts Meaningful
• uCern Medication Clinical Decision Support (mCDS)
• https://connect.ucern.com/groups/medication-clinical-decision-
support-mcds
Questions????

More Related Content

What's hot

Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...
Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...
Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...Trimed Media Group
 
2016 Value Reporting Measures and Services
2016 Value Reporting Measures and Services 2016 Value Reporting Measures and Services
2016 Value Reporting Measures and Services David Mills
 
Siemens Healthineers Award Write Up
Siemens Healthineers Award Write UpSiemens Healthineers Award Write Up
Siemens Healthineers Award Write UpClaudia Toscano
 
Special Report: Getting the Optimal Return on X-ray Equipment
Special Report: Getting the Optimal Return on X-ray EquipmentSpecial Report: Getting the Optimal Return on X-ray Equipment
Special Report: Getting the Optimal Return on X-ray EquipmentCarestream
 
ACR Select: Clinical Decision Support Imaging Guidelines
ACR Select: Clinical Decision Support Imaging GuidelinesACR Select: Clinical Decision Support Imaging Guidelines
ACR Select: Clinical Decision Support Imaging GuidelinesACR Select
 
January February 2009 E Newsletter
January February 2009 E NewsletterJanuary February 2009 E Newsletter
January February 2009 E NewsletterJudson P. Bruno
 
EiTESAL eHealth Conference 14&15 May 2017
EiTESAL eHealth Conference 14&15 May 2017 EiTESAL eHealth Conference 14&15 May 2017
EiTESAL eHealth Conference 14&15 May 2017 EITESANGO
 
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...Smarter Planet Students for a
 
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...Levi Shapiro
 
Corey Makes Healthcare - Coordinate, Efficient and Mobile
Corey Makes Healthcare - Coordinate, Efficient and MobileCorey Makes Healthcare - Coordinate, Efficient and Mobile
Corey Makes Healthcare - Coordinate, Efficient and MobileChandra Shekhar Tekwani
 
Midwest Regional Health - EHR
Midwest Regional Health - EHRMidwest Regional Health - EHR
Midwest Regional Health - EHRWILLIE GREER
 
Setting up a it deptt in a hospital
Setting up a it deptt in a hospitalSetting up a it deptt in a hospital
Setting up a it deptt in a hospitalPankaj Gupta
 
The Path to Shared Savings With Population Health Management Applications
The Path to Shared Savings With Population Health Management ApplicationsThe Path to Shared Savings With Population Health Management Applications
The Path to Shared Savings With Population Health Management ApplicationsHealth Catalyst
 
Sess08 My Back Up Brain
Sess08 My Back Up BrainSess08 My Back Up Brain
Sess08 My Back Up BrainEdward Stern
 
Smart Hospital Blueprint Sanitized
Smart Hospital Blueprint SanitizedSmart Hospital Blueprint Sanitized
Smart Hospital Blueprint Sanitizedssoliani
 
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_final
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_finalD1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_final
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_finalDr. Wilfred Lin (Ph.D.)
 
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide Atlantis Worldwide LLC
 
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound Software
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound SoftwareCaption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound Software
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound SoftwareEMMAIntl
 

What's hot (20)

Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...
Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...
Oklahoma State University Medical Center: CVIS Enhances Image Quality & Produ...
 
2016 Value Reporting Measures and Services
2016 Value Reporting Measures and Services 2016 Value Reporting Measures and Services
2016 Value Reporting Measures and Services
 
Siemens Healthineers Award Write Up
Siemens Healthineers Award Write UpSiemens Healthineers Award Write Up
Siemens Healthineers Award Write Up
 
Special Report: Getting the Optimal Return on X-ray Equipment
Special Report: Getting the Optimal Return on X-ray EquipmentSpecial Report: Getting the Optimal Return on X-ray Equipment
Special Report: Getting the Optimal Return on X-ray Equipment
 
ACR Select: Clinical Decision Support Imaging Guidelines
ACR Select: Clinical Decision Support Imaging GuidelinesACR Select: Clinical Decision Support Imaging Guidelines
ACR Select: Clinical Decision Support Imaging Guidelines
 
January February 2009 E Newsletter
January February 2009 E NewsletterJanuary February 2009 E Newsletter
January February 2009 E Newsletter
 
EiTESAL eHealth Conference 14&15 May 2017
EiTESAL eHealth Conference 14&15 May 2017 EiTESAL eHealth Conference 14&15 May 2017
EiTESAL eHealth Conference 14&15 May 2017
 
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...
IBM Smarter Healthcare presentation - Angus Campbell - Smarter planet comes t...
 
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...
Purna Prasad- Transformation of Healthcare Technology into the Commodity (Con...
 
E healthcare
E healthcare E healthcare
E healthcare
 
Corey Makes Healthcare - Coordinate, Efficient and Mobile
Corey Makes Healthcare - Coordinate, Efficient and MobileCorey Makes Healthcare - Coordinate, Efficient and Mobile
Corey Makes Healthcare - Coordinate, Efficient and Mobile
 
Midwest Regional Health - EHR
Midwest Regional Health - EHRMidwest Regional Health - EHR
Midwest Regional Health - EHR
 
Setting up a it deptt in a hospital
Setting up a it deptt in a hospitalSetting up a it deptt in a hospital
Setting up a it deptt in a hospital
 
The Path to Shared Savings With Population Health Management Applications
The Path to Shared Savings With Population Health Management ApplicationsThe Path to Shared Savings With Population Health Management Applications
The Path to Shared Savings With Population Health Management Applications
 
Sess08 My Back Up Brain
Sess08 My Back Up BrainSess08 My Back Up Brain
Sess08 My Back Up Brain
 
Smart Hospital Blueprint Sanitized
Smart Hospital Blueprint SanitizedSmart Hospital Blueprint Sanitized
Smart Hospital Blueprint Sanitized
 
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_final
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_finalD1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_final
D1 1130 hee hwang hong kong presentation hee_hwang(0704)_public_final
 
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
 
Hfma 2014
Hfma 2014Hfma 2014
Hfma 2014
 
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound Software
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound SoftwareCaption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound Software
Caption Guidance – FDA’s First Authorized AI-Based Cardiac Ultrasound Software
 

Viewers also liked

Assign 15 - Analysing Websites for Brands and Artists
Assign 15 - Analysing Websites for Brands and ArtistsAssign 15 - Analysing Websites for Brands and Artists
Assign 15 - Analysing Websites for Brands and ArtistsMediagroup5
 
TOPOLOGIA ASIGNADA
TOPOLOGIA ASIGNADATOPOLOGIA ASIGNADA
TOPOLOGIA ASIGNADAandreseams
 
INVENTARIO DE RECURSOS DE SOFTWARE
INVENTARIO DE RECURSOS DE SOFTWAREINVENTARIO DE RECURSOS DE SOFTWARE
INVENTARIO DE RECURSOS DE SOFTWAREandreseams
 
Magazine 3 choices
Magazine 3 choicesMagazine 3 choices
Magazine 3 choicesaaron_cork
 
Localización y organización de información científica
Localización y organización de información científicaLocalización y organización de información científica
Localización y organización de información científicaBiblioteca Campus Gandia CRAI
 
No effort pizza which kids adore
No effort pizza which kids adoreNo effort pizza which kids adore
No effort pizza which kids adoreEran Solomon
 
Mell - your opinion matters
Mell - your opinion mattersMell - your opinion matters
Mell - your opinion mattersxavey
 
Medicamentos Biológicos
Medicamentos BiológicosMedicamentos Biológicos
Medicamentos BiológicosPriscila Torres
 
QGIS 소개 및 ArcMap과의 비교
QGIS 소개 및 ArcMap과의 비교QGIS 소개 및 ArcMap과의 비교
QGIS 소개 및 ArcMap과의 비교BJ Jang
 
기상과 공간정보기술(GIS)의만남
기상과 공간정보기술(GIS)의만남기상과 공간정보기술(GIS)의만남
기상과 공간정보기술(GIS)의만남SANGHEE SHIN
 
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...yovitakristiani_ tolanda
 
Cerner CPOE PowerPlan Builder 101
Cerner CPOE PowerPlan Builder 101Cerner CPOE PowerPlan Builder 101
Cerner CPOE PowerPlan Builder 101cparry87
 

Viewers also liked (13)

Assign 15 - Analysing Websites for Brands and Artists
Assign 15 - Analysing Websites for Brands and ArtistsAssign 15 - Analysing Websites for Brands and Artists
Assign 15 - Analysing Websites for Brands and Artists
 
TOPOLOGIA ASIGNADA
TOPOLOGIA ASIGNADATOPOLOGIA ASIGNADA
TOPOLOGIA ASIGNADA
 
INVENTARIO DE RECURSOS DE SOFTWARE
INVENTARIO DE RECURSOS DE SOFTWAREINVENTARIO DE RECURSOS DE SOFTWARE
INVENTARIO DE RECURSOS DE SOFTWARE
 
Magazine 3 choices
Magazine 3 choicesMagazine 3 choices
Magazine 3 choices
 
Competencias en información para la elaboración del Trabajo Fin de Grado (Fac...
Competencias en información para la elaboración del Trabajo Fin de Grado (Fac...Competencias en información para la elaboración del Trabajo Fin de Grado (Fac...
Competencias en información para la elaboración del Trabajo Fin de Grado (Fac...
 
Localización y organización de información científica
Localización y organización de información científicaLocalización y organización de información científica
Localización y organización de información científica
 
No effort pizza which kids adore
No effort pizza which kids adoreNo effort pizza which kids adore
No effort pizza which kids adore
 
Mell - your opinion matters
Mell - your opinion mattersMell - your opinion matters
Mell - your opinion matters
 
Medicamentos Biológicos
Medicamentos BiológicosMedicamentos Biológicos
Medicamentos Biológicos
 
QGIS 소개 및 ArcMap과의 비교
QGIS 소개 및 ArcMap과의 비교QGIS 소개 및 ArcMap과의 비교
QGIS 소개 및 ArcMap과의 비교
 
기상과 공간정보기술(GIS)의만남
기상과 공간정보기술(GIS)의만남기상과 공간정보기술(GIS)의만남
기상과 공간정보기술(GIS)의만남
 
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...
Presentasi proposal penelitian TA respon pertumbuhan bibit kelapa sawit terha...
 
Cerner CPOE PowerPlan Builder 101
Cerner CPOE PowerPlan Builder 101Cerner CPOE PowerPlan Builder 101
Cerner CPOE PowerPlan Builder 101
 

Similar to chc_2015

Monitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectMonitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectSplunk
 
Clinical Information System
Clinical Information SystemClinical Information System
Clinical Information SystemFreeman Hospital
 
Monitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectMonitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectSplunk
 
QoC Health - Hacking Health presentation - Sarah Sharpe
QoC Health - Hacking Health presentation - Sarah SharpeQoC Health - Hacking Health presentation - Sarah Sharpe
QoC Health - Hacking Health presentation - Sarah SharpeJenna Blumenthal
 
Open app challenge phase 1 submission team recommind
Open app challenge   phase 1 submission team recommindOpen app challenge   phase 1 submission team recommind
Open app challenge phase 1 submission team recommindKathleenAller
 
Modern Health Care System - Daktarz
Modern Health Care System - DaktarzModern Health Care System - Daktarz
Modern Health Care System - DaktarzAkash Goyal
 
1-4 An Introduction to Clinical Informatics: Clinical Information Systems
1-4 An Introduction to Clinical Informatics: Clinical Information Systems1-4 An Introduction to Clinical Informatics: Clinical Information Systems
1-4 An Introduction to Clinical Informatics: Clinical Information SystemsCorinn Pope
 
Salud digital: Big Data y tecnologías digitales para la mejora de resultados
Salud digital: Big Data y tecnologías digitales para la mejora de resultadosSalud digital: Big Data y tecnologías digitales para la mejora de resultados
Salud digital: Big Data y tecnologías digitales para la mejora de resultadosAMETIC
 
Open appchallenge phase1submission-hrs
Open appchallenge phase1submission-hrsOpen appchallenge phase1submission-hrs
Open appchallenge phase1submission-hrsRohan Udeshi
 
HealthPasskey
HealthPasskeyHealthPasskey
HealthPasskeyhinsys
 
Clear Roadmap
Clear RoadmapClear Roadmap
Clear RoadmapiPocrate
 
Cybersecurity Program Assessments
Cybersecurity Program AssessmentsCybersecurity Program Assessments
Cybersecurity Program AssessmentsJohn Anderson
 
Building on cerner with smart on fhir fhir dev days 2017
Building on cerner with smart on fhir   fhir dev days 2017Building on cerner with smart on fhir   fhir dev days 2017
Building on cerner with smart on fhir fhir dev days 2017DevDays
 
HRS - Allscripts OpenApp Challenge Phase 1
HRS - Allscripts OpenApp Challenge Phase 1HRS - Allscripts OpenApp Challenge Phase 1
HRS - Allscripts OpenApp Challenge Phase 1Rohan Udeshi
 
Diagnotes open app challenge - phase 1 submission
Diagnotes   open app challenge - phase 1 submissionDiagnotes   open app challenge - phase 1 submission
Diagnotes open app challenge - phase 1 submissionDiagnotes
 
Allscripts open app challenge slide deck final
Allscripts open app challenge slide deck finalAllscripts open app challenge slide deck final
Allscripts open app challenge slide deck finalCaraballo07
 
More Than OK Innovation in Care Transistions
More Than OK Innovation in Care TransistionsMore Than OK Innovation in Care Transistions
More Than OK Innovation in Care TransistionsInnoTech
 
2016_1_25_ResumeRNapier
2016_1_25_ResumeRNapier2016_1_25_ResumeRNapier
2016_1_25_ResumeRNapierRobin Napier
 

Similar to chc_2015 (20)

GEW nov 13 2017
GEW nov 13 2017GEW nov 13 2017
GEW nov 13 2017
 
Monitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectMonitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB Connect
 
Clinical Information System
Clinical Information SystemClinical Information System
Clinical Information System
 
Monitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB ConnectMonitoring a Database Driven System Utilizing Splunk's DB Connect
Monitoring a Database Driven System Utilizing Splunk's DB Connect
 
QoC Health - Hacking Health presentation - Sarah Sharpe
QoC Health - Hacking Health presentation - Sarah SharpeQoC Health - Hacking Health presentation - Sarah Sharpe
QoC Health - Hacking Health presentation - Sarah Sharpe
 
Open app challenge phase 1 submission team recommind
Open app challenge   phase 1 submission team recommindOpen app challenge   phase 1 submission team recommind
Open app challenge phase 1 submission team recommind
 
EHR & Healthcare
EHR & HealthcareEHR & Healthcare
EHR & Healthcare
 
Modern Health Care System - Daktarz
Modern Health Care System - DaktarzModern Health Care System - Daktarz
Modern Health Care System - Daktarz
 
1-4 An Introduction to Clinical Informatics: Clinical Information Systems
1-4 An Introduction to Clinical Informatics: Clinical Information Systems1-4 An Introduction to Clinical Informatics: Clinical Information Systems
1-4 An Introduction to Clinical Informatics: Clinical Information Systems
 
Salud digital: Big Data y tecnologías digitales para la mejora de resultados
Salud digital: Big Data y tecnologías digitales para la mejora de resultadosSalud digital: Big Data y tecnologías digitales para la mejora de resultados
Salud digital: Big Data y tecnologías digitales para la mejora de resultados
 
Open appchallenge phase1submission-hrs
Open appchallenge phase1submission-hrsOpen appchallenge phase1submission-hrs
Open appchallenge phase1submission-hrs
 
HealthPasskey
HealthPasskeyHealthPasskey
HealthPasskey
 
Clear Roadmap
Clear RoadmapClear Roadmap
Clear Roadmap
 
Cybersecurity Program Assessments
Cybersecurity Program AssessmentsCybersecurity Program Assessments
Cybersecurity Program Assessments
 
Building on cerner with smart on fhir fhir dev days 2017
Building on cerner with smart on fhir   fhir dev days 2017Building on cerner with smart on fhir   fhir dev days 2017
Building on cerner with smart on fhir fhir dev days 2017
 
HRS - Allscripts OpenApp Challenge Phase 1
HRS - Allscripts OpenApp Challenge Phase 1HRS - Allscripts OpenApp Challenge Phase 1
HRS - Allscripts OpenApp Challenge Phase 1
 
Diagnotes open app challenge - phase 1 submission
Diagnotes   open app challenge - phase 1 submissionDiagnotes   open app challenge - phase 1 submission
Diagnotes open app challenge - phase 1 submission
 
Allscripts open app challenge slide deck final
Allscripts open app challenge slide deck finalAllscripts open app challenge slide deck final
Allscripts open app challenge slide deck final
 
More Than OK Innovation in Care Transistions
More Than OK Innovation in Care TransistionsMore Than OK Innovation in Care Transistions
More Than OK Innovation in Care Transistions
 
2016_1_25_ResumeRNapier
2016_1_25_ResumeRNapier2016_1_25_ResumeRNapier
2016_1_25_ResumeRNapier
 

chc_2015

  • 1. Rachel Hagemann, RPh Krista Sanders, CPhT October 10, 2015 Cerner Millennium®: mCDS – Making Clinical Alerts Meaningful
  • 2. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 1 Learning Record Transfer • Transfer Learning Record from CLM to uLearn • If you have not already done this. • https://ulearn.cerner.com • Sign in with your Cerner Care email address and password. • Follow instructions on main page. • If you have questions about your learning record, please contact LearningSolutions@Cerner.com
  • 3. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 2 Objectives • Understand clinical alerts • Understand meaningful alerts • Be able to use the functionality within medication clinical decision support (mCDS) to create meaningful alerts
  • 4. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 3 Agenda • mCDS Introduction • Venue of Care Filtering • Preferences • Customization • Drug Allergies • Drug Drug • Duplication Checking • Repeat Numbers • Using Discern Rules • Discern alerts displayed within mCDS • Filtering drug drug interactions using discern rules • Order Detail Filtering • TPNs • Alert Maintenance • Questions/Examples
  • 5. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 4 Scheduled Break Times • After Venue of Care Filtering • Lunch • Noon • Snack • 2:10 • PRN
  • 7. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 6 mCDS Objective Is that Cerner solutions no longer filters medication alerts that are a nuisance, but create meaningful alerts that enhance safety and improve patient care.
  • 8. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 7 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 9. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 8 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 10. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 9 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 11. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 12. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 13. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 Packages • mCDS package • Innovations Dev (US): Medication Clinical Decision Support Window • Need 83848 or higher • MultumCustom.exe • Need 68066 or higher
  • 14. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 Nuisance Alerts • Not unique to Cerner solutions • Have seen studies where up to 85% of the alerts are ignored • Not unique to drug content provider • Cerner Multum • FDB (First Databank) • Medi-Span • Varies across venues of care • Ambulatory vs. Inpatient
  • 15. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 What’s the cause of nuisance alerts? • Conservative nature of content produced by commercial vendors • Cerner Multum/FDB/Medi-Span • Lack of context from not considering available data, objectives, role, and venue of care
  • 16. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 15 Approach to reducing nuisance alerts has been to reduce the “noise”, not to make them meaningful • Turn alerting off • Mainly drug drug and duplicate therapy • Leave allergy checking on • Disable lower severity alerts • “Fine tune” higher severity alerts • Government recommendations (FDA)
  • 19. 18 JAMIA Article – Duplicate Therapy Checking
  • 21. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 20 mCDS Development Approach • Improve the user experience • Enhance the user interface • Address major functional gaps/limitations • Improve ability to “localize” the experience • Required changes and “tightening” • Meaningful use • “Bugs”/Client feedback • Incorporate Discern capabilities • Filter alerts based upon order details • Existing ADE packages, local rules • Utilize future Cerner capabilities • Cerner Math • DAAKOS • Hansten and Horn
  • 22. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 21 Meaningful Use • Stage 1 • Drug allergy checking • Drug drug interaction checking • Stage 2 • Citations • Allergies • Drug Interactions • Requirements • mCDS window • Latest/Greatest Cerner Multum content package • Stage 3 • Cerner working on requirements
  • 25. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 24 Drug Drug Interaction Citation • Select icon next to the drug interaction pair to display
  • 26. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 25 AHS_FL Alert Reduction since implementing mCDS Window
  • 28. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 27 Window Improvements • Window defaults to all sections open – ability to collapse individual sections or all sections • Triggering and existing medications display honors MNEM_DISP_LEVEL preference • Additional order information available via order detail tool tip • Triggering and existing medications display Simplified Display Line • Drug reference, patient leaflets, and alert history accessed from hyperlink on medication order • Ability to discontinue medication being ordered and profile medication from the mCDS window
  • 29. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 28 Window Improvements • Ability to identify orders as historical, prescription, or an inpatient medication order • Severity level of interaction is displayed in text, not an icon, with Major Contraindicated interactions color coded in red • Access additional interaction information via a hyperlink • Allergy and drug drug interaction citation information available
  • 30. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 29 Allergy Improvements • Access allergy control via a hyperlink • Allergy Comments, Reaction Type, and Information Source are displayed • Allergy Citation information is available – Meaningful Use requirement
  • 31. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 30 Override Reasons Improvements • Override Reason selection available for individual alerts • Previous Override Reason is available • “Apply to All” Override Reasons configurable in Bedrock
  • 32. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 31 mCDS Alert Override Reasons • Design Decisions • Not Required • Required • Which application(s) • Which alert type(s) • Which provider(s) • Which individual(s) • Configure in PrefMaint.exe • PowerChart  Chart  PowerOrders • MUL_OVERRIDEREQUIRED (0 =Override Reason not required; 1= Override Reason Required) • MUL_OVERRIDEREQUIRED_TYPE • Pharmacy • MUL_OVERRIDEREQUIRED_TYPE • Bedrock • Override Reason filters for All Alert Types and each specific Alert Type
  • 33. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 32 Requiring Override Reasons in PowerChart • Configure in PrefMaint.exe • PowerChart  Chart  PowerOrders  MUL_OVERRIDEREQUIRED and MUL_OVERRIDEREQUIRED_TYPES
  • 34. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 33 Requiring Override Reasons in Med Manager • Configure in PrefMaint.exe • Pharmacy  MUL_OVERRIDEREQUIRED_TYPES
  • 35. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 34 Override Reasons Display • Bedrock Override Reasons Filters • In order for an Override Reason to be available for “Apply to All” it must be included in the “Override Reason for all Types” filter
  • 36. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 35 mCDS Discontinue Reasons • Design Decisions • Not Required • Required • What reasons to display • Configure • DCPTools.exe  Order Management  Order Entry Format Tool  Formats  Pharmacy Order Entry Formats  Discontinue Order Action  Discontinue Reasons Field • Discontinue format build is required or mCDS window will display an error • Selections for field: Do Not Display, Display Only, Optional, Required
  • 37. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 36 Discontinue Reason Format Selections for field: Do Not Display, Display Only, Optional, Required
  • 38. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 37 mCDS Discontinue Reasons • Must use code set 1309 for the drop down • DCPTools.exe  Order Management  Order Entry Format Tool  Fields  Discontinue Reason • Must use Meaning of Discontinue Reason
  • 39. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 38 Filtering Discontinue Reasons • Configure in Bedrock • Design, Build and Maintenance  Core – Orders  Order Entry Field Value (Code Set) Filtering  Discontinue Reason (Code Set 1309) • Catalog Type • Activity Type • Orderable
  • 40. Venue of Care Filtering
  • 41. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 40 Agenda for Venue of Care Filtering • Description • Diagrams • Diagrams – a second time • How to set up • Example • Questions????
  • 42. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 41 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 43. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 42 Venue of Care Filtering • Definition • Filtering of all alert types (drug drug, drug food, drug allergies, and duplicate therapy) when moving from home (prescriptions) to inpatient and back to prescriptions. • Rationale for filtering alerts • Reduction of nuisance alerts when patients move across venues of care (prescriptions (home) to inpatient to prescriptions). • Customization • Bedrock mCDS wizard
  • 44. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 43 Venue of Care Filtering • Applies to all alert types • Drug Drug • Drug Food • Drug Allergy • Duplicate Therapy • Filters are in Bedrock • Code set extension settings in CoreCodeBuilder.exe no longer honored • Home Medication to Inpatient Filtering (HXIP) • Inpatient Filtering (IP) • Inpatient to Prescription Filtering (IPRX) • Prescription Filtering (RX) • Filtering applies to all solutions and position codes
  • 45. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 44 Venue Filters Off • When all venue of care filters are off, checking will occur across documented home medications, inpatient orders, and prescription orders.
  • 46. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 45 Venue of Care Filtering • Venue of Care Filtering
  • 47. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 46 Venue of Care Filtering -- HXIP • No alerts • HXIP filtering on – No checking against medications when moving from home meds to inpatient orders • potassium chloride and diphenhydrAMINE drug drug interaction suppressed • diphenhydrAMINE and loratadine duplicate checking suppressed • same orderable duplicate checking suppressed • This filter will always occur across solutions HXIP Alerts Filtered
  • 48. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 47
  • 49. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 48 Venue of Care Filtering -- IP • No alerts • IP filtering on – No checking between medications continued as inpatient orders • Potassium chloride and diphenhydrAMINE drug drug interaction suppressed • diphenhydrAMINE and loratadine duplicate checking suppressed • One time blocking • Second time (e.g., verification by pharmacy) will see this alert IP Alerts Filtered
  • 50. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 49
  • 51. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 50 Venue of Care Filtering -- IPRX • No alerts • IPRX filtering on – No checking against inpatient medications when moving from inpatient meds to prescription orders • This filter will always occur across solutions IPRX Alerts Filtered
  • 52. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 51
  • 53. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 52 Venue of Care Filtering -- RX • No alerts • RX filtering on – No checking between inpatient medications continued as prescription orders  Alert Checking does occur for medications that were not continued from inpatient order – hydrOXYzine was not an inpatient medication • One time blocking • Second time will see this alert RX Alerts Filtered
  • 54. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 53
  • 55. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 54
  • 56. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 55 Venue of Care Filtering • Venue of Care Filtering
  • 57. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 56 Venue of Care Filtering • Bedrock.exe  Quality Reporting and MPages  MPage Setup  Medication Clinical Decision Support (mCDS)
  • 58. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 57 Venue of Care Filtering • Home Medication to Inpatient Filtering
  • 59. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 58 Venue of Care Filtering • Home Medication to Inpatient Filtering • This setting determines if clinical checking will be filtered between history and inpatient venues. This filter will be used when an order moves from history to inpatient venue(s) of care or an inpatient order is placed.
  • 60. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 59 Venue of Care Filtering • Home Medication to Inpatient Filtering
  • 61. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 60 CoreCodeBuilder.exe
  • 62. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 61 Venue of Care Filtering • Inpatient Filtering • This setting is used to determine how clinical checking is filtered during the patient’s inpatient stay. If enabled, one-time blocking of clinical checking (drug drug, drug food, drug allergy, duplicate therapy) will occur within the “inpatient” venue of care.
  • 63. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 62 Venue of Care Filtering • Inpatient Medication Filtering
  • 64. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 63 Venue of Care Filtering • Inpatient to Prescription • This setting determines if clinical checking will be filtered between inpatient and discharge venues. This filter will be used when an order moves from inpatient to discharge venue(s) of care or an inpatient or prescription order is placed.
  • 65. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 64 Venue of Care Filtering • Inpatient to Prescription Filtering
  • 66. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 65 Venue Filtering • Prescription Filtering • This setting is used to determine how clinical checking is filtered when prescriptions are prescribed. If enable, one-time blocking of clinical checking (drug drug, drug food, drug allergy, duplicate therapy) will occur within the discharge venue of care.
  • 67. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 66 Venue of Care Filtering • Prescription Filtering
  • 68. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 67 Venue of Care Filtering • Example • HXIP – On • IP – On • IPRX – On • RX – On
  • 69. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 68
  • 70. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 69 Venue of Care Filtering • No alerts • No duplicate checking against the same medications because of HXIP from hx meds to inpatient orders • IP blocked inpatient orders • Potassium chloride and diphenhydrAMINE drug drug interaction • diphenhydrAMINE and loratadine duplicate checking
  • 71. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 70 Venue of Care Filtering • Alert when ordering potassium chloride IV • Potassium chloride IV was not a hx med therefore it checked against all current inpatient orders
  • 72. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 71 Venue of Care Filtering • Orders to be verified by pharmacy • The one time blocking has occurred in PowerChart therefore there will not be any IP blocking when verifying • If orders are entered directly in PharmNet then the one time blocking of IP will apply
  • 73. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 72 Venue of Care Filtering • Alert with diphenhydrAMINE and potassium chloride IV • The one time blocking has occurred in PowerChart therefore there will not be any IP blocking when verifying • If orders are entered directly in PharmNet then the one time blocking of IP will apply
  • 74. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 73 Venue of Care Filtering • Alert for loratadine and diphenhydrAMINE • The one time blocking has occurred in PowerChart therefore there will not be any IP blocking when verifying • If orders are entered directly in PharmNet then the one time blocking of IP will apply
  • 75. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 74 Venue of Care Filtering • Alert when verifying potassium chloride IV • Potassium chloride IV was not a hx med therefore it checked against all current inpatient orders
  • 76. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 75 Venue of Care Filtering • Pharmacy orders are verified
  • 77. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 76 Venue of Care Filtering • Discharging the patient • No alerts • No duplicate checking against the same medications because of IPRX from inpatient meds to prescription orders • RX blocked prescription orders • Potassium chloride and diphenhydrAMINE drug drug interaction • diphenhydrAMINE and loratadine duplicate checking
  • 78. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 77 Venue of Care Filtering • Alert against the home medication hydrOXYzine and diphenhydrAMINE • hydrOXYzine was a hx med and not an inpatient medication therefore it will be checked against prescription medications
  • 79. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 78 Venue of Care Filtering • Alert against the home medication hydrOXYzine and loratadine • hydrOXYzine was a hx med and not an inpatient medication therefore it will be checked against prescription medications
  • 80. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 79 Venue of Care Filtering • Alert against the home medication hydrOXYzine and potassium chloride • hydrOXYzine was a hx med and not an inpatient medication therefore it will be checked against prescription medications
  • 81. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 80 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 82. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 81 Venue of Care Filtering • Venue of Care Filtering • Questions????
  • 83. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 82 “Mr. Osborne, may I be excused? My brain is full.”
  • 85. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 84
  • 86. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 85 MULPREF • Turns on Multum within Matrix Orders. • 1-On • 0-Off
  • 87. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 86 MUL_DS_STYLE • This preference determines the style of the interaction checking window. • 1-Use enhanced window • 0-Use classic window
  • 88. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 87 MUL_MPAGE_VIEW • Determines if the Medication Clinical Decision Support (mCDS) view is enabled for Multum interaction checking. When the value is set to 1 or 2, the preference MUL_DS_STYLE=1 (Use Enhanced View) must also be set. • 1-On for Add Order or Product • 0-Off • 2-On for Sign Order or OK
  • 89. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 88 MUL_OVERRIDEREQUIRED • This preference determines whether an Override Reason must be entered in order to close the alert window. • 1-Override reason required • 0-Override reason not required
  • 90. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 89 MULINTR • This preference determines whether to perform interaction checking when medication orders are placed using Matrix Orders. • 1-Interaction checking • 0-No interaction checking
  • 91. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 90 MUL_INTRSEVERITY • This preference determines at what level interaction checking will occur. • 5-Major Contraindicated • 3-Major • 2-Moderate • 1-Minor
  • 92. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 91 MUL_INTERPRETEDSEVERITY • This preference determines if interaction checking should be performed based on traditional Multum severities or on interpreted severities using the interaction severity and interaction severity heading. Note that any customized severities will override the interpreted severity. • 0-Use traditional Multum severities • 1-Use interpreted severities
  • 93. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 92 MULREAT • This preference determines whether to perform allergy checking for medication orders using Matrix Orders. • 1-Allergy checking • 0-No allergy checking
  • 94. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 93 MUL_ALLERGYINTERRUPTION • Determines whether to display the interaction checking window for allergy reactions. • 0-Display • 1-Do not display
  • 95. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 94 MUL_ALLERGY_REACTIONCLASS_FILTER • This preference determines which types of allergy reaction class's should be filtered out of drug-allergy and reverse allergy interaction checking. This preference is only used when MUL_DS_STYLE is set to 1. • The preference is a comma-separated list of allergy reaction class codes from code set 12021. For example “3291,3292” • Adverse Effect • Side Effect
  • 96. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 95 MULDUP • This preference determines whether to perform duplicate checking when medication orders are placed using Matrix Orders. • 1-Duplicate checking • 0-No duplicate checking
  • 97. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 96 MUL_DUPINTERRUPTION • This preference determines whether the interaction checking window will display when ordering duplicate medications. • 0-Display • 1-Do not display
  • 98. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 97 MULDUPCHECKPREF • This preference determines the manner in which duplicate checking is performed for Pharmacy orders. • 2-Dups against both • 0-Dups against scratchpad • 1-Dups against existing orders • 3-Dups against scratchpad minus same CKI’s • 4-Dup against sp minus same cki and existing
  • 99. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 98 MULDUPMODE • This preference determines when the duplicate checking window will display. • 2-Both • 0-Single Drug • 1-Category
  • 100. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 99 MULDUPCAT • This preference determines the level of duplicate checking when different drugs have identical or similar clinical effects. This preference is only used when MULDUPMODE is set to Category or Both. • C-Very Specific • B-General • A-Very General
  • 101. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 0 MULDUPCLASS • This preference determines whether duplicate therapy checking should be applied across both inpatient and outpatient drugs or to check exclusively inpatient or outpatient drugs. • 1-Mutually Exclusive • 0-All
  • 103. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 2
  • 104. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 3 MultumCustom.exe Drug Drug Interaction • Severity • Severity Header • Suppression • Text Duplicate Therapy Checking • Repeat Numbers – Must have package number 68066 or higher installed • Duplication Category • Drug • Suppression • Duplication Category • Drug Drug Allergy Checking • Drug to Drug • Allergy Category to Drug Reference Text
  • 105. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 4 Duplicate Therapy • Suppression •Duplication Category • Drug • Repeat Number • Duplication Category • Drug
  • 106. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 5 Duplication Therapy Searches Drug • Individual drug Category • All individual drugs within a drug category Duplication Category • The actual duplication category
  • 107. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 6 Duplicate Therapy • Example • Laxatives • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About +Medication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 108. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 7 Drug Allergy • Allergy Category • Suppression of documented allergy category • Additional searches • Allergy Category Drug • The documented allergy category to a drug • Allergy Category Category • The documented allergy category to all individual drugs within a drug category
  • 109. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 8 Drug Allergy Drug Drug • Individual drugs • e.g. oxyCODONE / meperidine Category Drug • All individual drugs within a drug category to a drug • e.g. penicillins / aztreonam Category Category • All individual drugs within categories • e.g. loop diuretics / sulfonamides Allergy Category Drug • The documented allergy category to a drug • e.g. penicillins / aztreonam Allergy Category Category • The documented allergy category to all individual drugs within a drug category • e.g. loop diuretics / Sulfa drugs
  • 110. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 10 9 Drug Allergy • Example • Sulfa Drugs and Loop Diuretics • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About +Medication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 111. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 0 Drug Allergy Suppression Client Example Suppression loop diuretics (category) / sulfonamides (category) loop diuretics (category) / sulfa drugs (allergy category) loop diuretics (category) / sulfonamides (allergy category) loop diuretics (category) / COX-2 inhibitors (category) penicillins (allergy category) / aztreonam (drug) penicillins (category) / aztreonam (drug) codeine (drug) / meperidine (drug) codeine (drug) / fentanyl (drug) morphine (drug) / meperidine (drug) oxyCODONE (drug) / meperidine (drug) oxyCODONE (drug) / fentanyl (drug) fentaNYL (drug) / HYDROmorphone (drug) meperidine (drug) / acetaminophen-oxycodone (drug) meperidine (drug) / HYDROmorphone (drug) acetaminophen-propoxyphene (drug) / HYDROmorphone (drug) acetaminophen-propoxyphene (drug) / acetaminophen-oxycodone (drug) acetaminophen-hydrocodone (drug) / meperidine (drug) nalbuphine (drug) / meperidine (drug) carbapenems (category) / third generation cephalosporins (category)
  • 112. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 111 Drug Allergy Suppression Most Questioned/Reviewed Sulfonamides and Related Compounds Classification carbonic anhydrase inhibitor sulfonylurea sulfonamide d00161 acetaZOLAMIDE d00162 acetoHEXAMIDE d04428 amprenavir d04301 brinzolamide ophthalmic d00042 chlorproPAMIDE d04301 brinzolamide ophthalmic d00639 dichlorphenamide d03864 glimepiride d04380 celecoxib d03805 dorzolamide ophthalmic d00246 glipiZIDE d05825 darunavir d00640 methazolamide d00248 glyBURIDE d00129 diazoxide sulfa topical d00393 TOLAZamide d04901 fosamprenavir d01258 mafenide topical d00394 TOLBUTamide d00031 probenecid d01259 silver sulfADIAZINE topical thiazide or thiazide-like diuretic d08182 simeprevir d01208 sulfacetamide sodium ophthalmic d00641 bendroflumethiazide d00118 sulfADIAZINE d01265 sulfacetamide sodium topical d00644 benzthiazide d03742 sulfadoxine d01240 sulfanilamide topical d00190 chlorothiazide d01090 sulfamethizole d03980 sulfiSOXAZOLE ophthalmic d00253 hydrochlorothiazide d00119 sulfamethoxazole d03231 triple sulfa topical d00645 hydroflumethiazide d00379 sulfaSALAzine sulfonamide-type loop diuretic d00260 indapamide d00120 sulfiSOXAZOLE d00179 bumetanide d00643 methyclothiazide d07942 sulfonated phenolics topical d00070 furosemide d00647 polythiazide d04121 tamsulosin d03189 torsemide d00646 trichlormethiazide d05538 tipranavir sulfone thiazide-like diuretic d04778 valdecoxib d00098 dapsone d00192 chlorthalidone d04527 zonisamide d05543 dapsone topical d00299 metolazone
  • 113. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 2 Drug Allergy Suppression Most Questioned/Reviewed Penicillins and Related Drugs Classification beta lactamase inhibitor cephalosporin d04405 clavulanate d00081 cefaclor d04403 sulbactam d00080 cefadroxil d04404 tazobactam d00062 cefamandole carbapenem d00007 ceFAZolin d07049 doripenem d04256 cefdinir d04783 ertapenem d04767 cefditoren d04401 imipenem d03882 cefepime d04027 meropenem d00072 cefixime monobactam d00093 cefmetazole d00067 aztreonam d00063 cefonicid penicillin d00074 cefoperazone d00088 amoxicillin d00008 cefotaxime d00003 ampicillin d00055 cefoTEtan d00151 bacampicillin d00094 cefOXitin d00092 carbenicillin d00095 cefpodoxime d00152 cloxacillin d00073 cefprozil d00153 dicloxacillin d07706 ceftaroline d00107 methicillin d00009 cefTAZidime d00109 mezlocillin d03874 ceftibuten d00029 nafcillin d00010 ceftizoxime d00115 oxacillin d00052 cefTRIAXone d00116 penicillin d00056 cefuroxime d07727 penicillin G benzathine d00096 cephalexin d07729 penicillin G potassium d00186 cephalothin d07728 penicillin G sodium d00187 cephapirin d07730 penicillin V potassium d00053 cephradine d00057 piperacillin d00105 loracarbef d07390 procaine penicillin d00121 ticarcillin
  • 114. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 3 Drug Allergy Suppression Most Questioned/Reviewed Narcotic Analgesics Classification methadone-like opiate phenanthrene derivative d03187 levomethadyl acetate d04991 apomorphine d00050 methadone d00840 buprenorphine d00360 propoxyphene d00838 butorphanol opioid-like analgesic d04251 butorphanol nasal d03826 traMADol d00012 codeine phenylpiperidine derivative d00837 dezocine d00167 alfentanil d03168 dihydrocodeine d03069 difenoxin d03877 heroin (Schedule I substance) d03071 diphenoxylate d03075 HYDROcodone d00233 fentaNYL d00255 HYDROmorphone d04313 fentanyl topical d00825 levorphanol d00017 meperidine d00308 morphine d04034 remifentanil d05295 morphine liposomal d00378 SUFentanil d00839 nalbuphine d00824 opium d00329 oxyCODONE d00833 oxymorphone d00334 pentazocine
  • 115. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 4 Drug Drug • Suppression • Severity • Major • Moderate • Minor • Header Severity • Contraindicated • Major and Contraindicated is the major contraindicated preference • Generally Avoid • Monitor Closely • Adjust Dosing Interval • Adjust Dose • Additional Contraception Recommended • Monitor • Monograph Text
  • 116. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 5 Drug Drug Drug Drug • Individual drugs Category Drug • All individual drugs within a drug category to a drug Category Category • All individual drugs within categories
  • 117. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 6 Drug Drug • Example • Customizing to Major Contraindicated • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About +Medication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 119. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 8 Filtering Medication Alerts Using Discern Expert • Apply Discern Expert rules to interaction pairs • Display additional information • Suppress alerts based on patient parameters • The Discern Expert rule is built in Discern EKM Development application available in Discern Launch • Evoke MUST be SYNCHEVENT • Rule firing will not result in the mCDS window displaying; result will display when other alert types involving the interaction pair have fired, displaying the window • The Expert Synch trigger is included in multumcustom.exe
  • 120. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 11 9
  • 121. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 0
  • 122. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 1 Filtering Medication Alerts Using Discern Expert • Examples • Suppression drug drug interactions based on lab values • Displaying Lab Values • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 123. TPN
  • 124. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 3 TPN • Filters within the TPN when TPNs are built as an IV set • Alert before the filter is applied
  • 125. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 4 • Filtering duplication checking within a TPN • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful TPN
  • 127. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 6 Order Detail Filtering • Create meaningful alerts that enhance safety and improve patient care by making alert more patient specific.
  • 128. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 7 Order Detail Filtering • Examples • Filter out specific alerts for providers • Cardiologic vs. Infection Control Physician • Filter out alerts for due to specific routes • Anticholinergents and Potassium Chloride • Ciprofloxacin and Antacids • Allow multiple drugs to be ordered based on PRN reason • Narcotic Analgesics • Allow multiple drugs to be ordered based on frequency • Midazolam • Aspirin and NSAIDs
  • 129. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 8 Order Detail Filtering • Examples • Filter out specific alerts for providers • Cardiologic vs. Infection Control Physician • Filter out alerts for due to specific routes • Anticholinergents and Potassium Chloride • Ciprofloxacin and Antacids • Allow multiple drugs to be ordered based on PRN reason • Narcotic Analgesics • Allow multiple drugs to be ordered based on frequency • Midazolam • Aspirin and NSAIDs
  • 130. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 12 9 Order Detail Filtering • Examples • Filter out specific alerts for providers • Cardiologic vs. Infection Control Physician • Filter out alerts for due to specific routes • Anticholinergents and Potassium Chloride • Ciprofloxacin and Antacids • Allow multiple drugs to be ordered based on PRN reason • Narcotic Analgesics • Allow multiple drugs to be ordered based on frequency • Midazolam • Aspirin and NSAIDs
  • 131. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 0 Order Detail Filtering • Examples • Filter out specific alerts for providers • Cardiologic vs. Infection Control Physician • Filter out alerts for due to specific routes • Anticholinergents and Potassium Chloride • Ciprofloxacin and Antacids • Allow multiple drugs to be ordered based on PRN reason • Narcotic Analgesics • Allow multiple drugs to be ordered based on frequency • Midazolam • Aspirin and NSAIDs
  • 132. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 1 Order Detail Filtering • Examples • Filter out specific alerts for providers • Cardiologic vs. Infection Control Physician • Filter out alerts for due to specific routes • Anticholinergents and Potassium Chloride • Ciprofloxacin and Antacids • Allow multiple drugs to be ordered based on PRN reason • Narcotic Analgesics • Allow multiple drugs to be ordered based on frequency • Midazolam • Aspirin and NSAIDs
  • 133. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 2 Order Detail Filtering • Filtering alerts based on orderable or drug category and order entry format fields • Strength dose • Volume dose • Duration • Route • Dosage form • Frequency • PRN reason
  • 134. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 3 Order Detail Filtering • Build in Bedrock • Filtering of orderable and order details • When a second order is placed with the same data an alert will fire • Based on orderable or drug category • Based on order entry details • Can be based on provider’s position • At least one orderable/drug category and one order entry detail are required • Up to four different scenarios • Next package will have 10 filters
  • 135. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 4 Order Detail Filtering • Bedrock.exe  Quality Reporting and MPages  MPage Setup  Medication Clinical Decision Support (mCDS)  Order Detail Filtering Group
  • 136. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 5 Order Detail Filtering • Examples • Potassium Chloride and Anticholinergic Medications • Narcotics with Different PRN Reasons • Amlodipine and Strength of Simvastatin • Position Filtering • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 138. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 7 mCDS Set Up • Set preferences • Run Bedrock Wizard for Multum content • Up to date Multum content • Attach missing CKI’s • Use meds_cki_utility to remove incorrect CKI’s
  • 139. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 8 mCDS Set Up • Develop the scenario • Criteria for filtering • Primary level • Drug drug interactions • Drug allergies • Drug duplication • Criteria on patient’s profile • Lab values • Age • Order Detail Specific • PRN reason • Route • Doseform
  • 140. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 13 9 mCDS Set Up • For better maintenance customize or filter at the highest level • Preference • Multumcustom.exe • Drug drug interactions at primary level • Duplicate Therapy suppression and repeat numbers • Allergies at primary level • Discern Alerts • Lab Values • Age • Order Detail Filtering • PRN reason • Route • Doseform
  • 141. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 0 Trouble Shooting • Order Detail Filtering • Run scenario without filter and get an alert • This will let you know if there is something else not set correctly • CKI • Preference • Other Customizations • Set up filter • If multiple order details try setting one test and then set the second one • Run scenario not to receive an alert • Run scenario to receive an alert
  • 142. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 1 Trouble Shooting • When receiving an alert and not expecting an alert • Use the duplicate therapy text to find out if it is an individual drug or class duplicate
  • 143. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 2 Trouble Shooting • Use Check Interactions before signing the order.
  • 144. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 3 Trouble Shooting • Use Alert History when still verifying or ordering.
  • 145. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 4 Trouble Shooting • Use Alert History after the order has been signed.
  • 146. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 5 Trouble Shooting • Use Alert History after the order has been submitted.
  • 147. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 6 mCDS Set UP • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+ About+Medication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 149. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 8 Alert Maintenance • The ability to turn on alerts for only certain drug orderables or drug categories. • Allergies • Drug Duplicates • Set up in Bedrock
  • 150. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 14 9 Alert Maintenance • Alert Maintenance • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About +Medication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful
  • 152. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 15 1 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds
  • 153. BRNDEXP 2.1 0714 © 2014 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information belonging to Cerner Corporation and/or its related affiliates which may not be reproduced or transmitted in any form or by any means without the express written consent of Cerner 15 2 Documentation for mCDS • All About Medication Clinical Decision Support • Dashboard  Reference Pages  PharmNet Inpatient Reference Pages  All About Medication Clinical Decision Support • https://wiki.ucern.com/display/public/reference/All+About+Med ication+Clinical+Decision+Support • Go under the additional information hyperlink • Medication Clinical Decision Support (mCDS) Scenarios Build • Venue of Care Filtering PowerPoint • mCDS – Making Clinical Alerts Meaningful • uCern Medication Clinical Decision Support (mCDS) • https://connect.ucern.com/groups/medication-clinical-decision- support-mcds

Editor's Notes

  1. Drop around OCT-11 from implementing mCDS, primarily from filtering allergies (i.e. constipation vs anaphylaxis) Jan-12 drop is from implementing duplicate therapy with repeat numbers Slight drop in around February 12 is from localizing repeat numbers